Evidence map›Paper›PMID 41847336›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease2026

Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.

Nolwenn Jestin-Guyon, El Hassane Ouaalaya, Alain Bernady, Emilie Berteaud, Zamira Betancourt-Rial, Jean Moinard, Laurent Falque, Frédéric Le Guillou, Mathieu Molimard, Laurent Nguyen and 4 more

Abstract readMulticenter StudyComparative StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nolwenn Jestin-Guyon *UMR1219 Bordeaux Population Health, Bordeaux School of Public Health (ISPED), Bordeaux, France.
El Hassane Ouaalaya *High Institute of Nursing Professions and Health Techniques (ISPITS), Agadir University, Agadir, Morocco.ORCID 0000-0001-6584-4632
Alain Bernady *Department of Pulmonology, Cardio-Respiratory Medical Center Toki Eder, Combo-les-Bains, France.ORCID 0000-0002-3721-6812
Emilie Berteaud *UMR1219 Bordeaux Population Health, Bordeaux School of Public Health (ISPED), Bordeaux, France.
Zamira Betancourt-Rial *UMR1219 Bordeaux Population Health, Bordeaux School of Public Health (ISPED), Bordeaux, France.
Jean Moinard *Department of Pulmonology, Polyclinic Bordeaux Nord, Bordeaux, France.
Laurent Falque *Department of Pulmonology, Polyclinic Bordeaux Rive Droite, Lormont, France.
Frédéric Le Guillou *Pulmonology Clinic, La Rochelle, France.
Mathieu Molimard *Department of Clinical Pharmacology, Pellegrin University Hospital, Bordeaux, France.ORCID 0000-0002-4346-8346
Laurent Nguyen *Department of Pulmonology, Saint Augustin Clinic, Bordeaux, France.ORCID 0000-0002-3568-7733
Cécilia Nocent *Department of Pulmonology, Hospital Center Côte Basque, Bayonne, France.ORCID 0000-0002-2480-0649
Annaig Ozier *Department of Pulmonology, Saint Augustin Clinic, Bordeaux, France.
Mohammed Staali *Department of Pulmonology, Avicenne Rehabilitation Center, Libourne, France.
Chantal Raherison-Semjen *UMR1219 Bordeaux Population Health, Bordeaux School of Public Health (ISPED), Bordeaux, France.ORCID 0000-0003-0015-2883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Previous studies suggest that the clinical presentation of chronic obstructive pulmonary disease (COPD) is different between men and women. The aim of this study was to investigate sex-related differences and survival among COPD patients. Patients and Methods: Multicentric prospective real-life cohort. COPD patients (post-bronchodilator FEV Results: A total of 3265 patients included, with 36.7% women. Women had an increased risk of ≥2 exacerbations (aOR=1.79; Conclusion: COPD is more severe in women however men have a higher risk of mortality. Clinical features and mortality in men and women with COPD are different in our cohort. Further studies are needed to elucidate sex-related differences among COPD patients.

Indexed as

Health Status DisparitiesLungPulmonary Disease, Chronic ObstructiveAgedChi-Square DistributionDisease ProgressionDyspneaFemaleForced Expiratory VolumeFranceHumansKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedMultivariate AnalysisCOPDexacerbationsmortalitywomen

Identifiers

PMID41847336
PMCPMC12991284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.